id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-322009-0cwljo0c	Ma, Ling	Coinfection of SARS-CoV-2 and Other Respiratory Pathogens	2020-08-26		.txt	text/plain	3793	170	42	Although the number of confirmed global cases of COVID-19 now exceeds 16 million, as of July 29, and several retrospective observational studies have noted that coinfection with other respiratory pathogens is relatively common, [1] [2] [3] [4] the clinical features of coinfection and its impact on patient outcomes, is yet to be clarified. All these patients were tested for SARS-CoV-2, respiratory syncytial virus, influenza A virus, influenza B virus, adenovirus, Chlamydia pneumoniae, and Mycoplasma pneumoniae, using sputum or nasopharyngeal swab specimens collected in the interval between the onset of symptoms, and up to seven days after their hospital admission. Routine laboratory tests, including tests for SARS-CoV-2 and other common respiratory viral and atypical bacterial pathogens, routine blood investigations, coagulation studies, organ function tests and inflammatory biomarkers, such as c-reactive protein (CRP) and procalcitonin (PCT), were taken at the time of patient presentation, while the serum interleukin (IL)-2, IL-4, IL-6, IL-10, TNF-α and IFN-γ levels were obtained on the 2nd day of admission.	./cache/cord-322009-0cwljo0c.txt	./txt/cord-322009-0cwljo0c.txt